Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Harvard Business School
AstraZeneca
Merck
McKesson

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR BELVIQ XR


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Belviq Xr

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01880502 ↗ Pharmacokinetic Study of Belviq in Adult Korean Volunteers Completed IlDong Pharmaceutical Co Ltd Phase 1 2013-06-01 A randomized, double-blind, placebo-controlled, single-dose, dose escalation study (Phase I) to evaluate the tolerability and pharmacokinetics of Belviq in adult Korean volunteers.
NCT01962402 ↗ Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot Study Unknown status Southern California Institute for Research and Education Phase 4 2014-01-01 The purpose of this study is to determine whether lorcaserin is effective for weight reduction in patients with weight gain as a result of antipsychotic medications.
NCT02019264 ↗ A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Mul Completed Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization Phase 4 2014-01-24 This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study in overweight and obese subjects with cardiovascular (CV) disease and/or multiple CV risk factors.
NCT02019264 ↗ A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Mul Completed Eisai Inc. Phase 4 2014-01-24 This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study in overweight and obese subjects with cardiovascular (CV) disease and/or multiple CV risk factors.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Belviq Xr

Condition Name

Condition Name for Belviq Xr
Intervention Trials
Obesity 5
Smoking Cessation 3
Overweight 3
Cannabis Use Disorder 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Belviq Xr
Intervention Trials
Disease 7
Weight Loss 5
Overweight 5
Tobacco Use Disorder 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Belviq Xr

Trials by Country

Trials by Country for Belviq Xr
Location Trials
United States 99
Australia 6
New Zealand 6
Canada 5
Mexico 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Belviq Xr
Location Trials
New York 6
North Carolina 6
California 6
Virginia 5
Ohio 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Belviq Xr

Clinical Trial Phase

Clinical Trial Phase for Belviq Xr
Clinical Trial Phase Trials
Phase 4 6
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Belviq Xr
Clinical Trial Phase Trials
Completed 11
Terminated 10
Unknown status 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Belviq Xr

Sponsor Name

Sponsor Name for Belviq Xr
Sponsor Trials
National Institute on Drug Abuse (NIDA) 8
Eisai Inc. 3
New York State Psychiatric Institute 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Belviq Xr
Sponsor Trials
Other 23
NIH 11
Industry 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Express Scripts
AstraZeneca
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.